• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

Comparative Study of Efficacy of 0.5% Ropivacaine and 0.25% Levobupivacaine When Used in Transversus Abdominis Plane Block for Post-Operative Analgesia in Lower Abdominal Surgeries

    Dr. Satyendra Kumar, Dr. Zubia Anjum, Dr. [Prof.] Ashok Kumar, Dr. Bijoy Kumar,

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 1313-1321

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Transversus abdominis plane block (TAPB) is a regional anaesthesia technique. Analgesia is given following lower abdomen surgery, especially if parietal wall pain is a significant cause of suffering. Local anaesthetic deposition can be used to visually block the skin of the lower abdominal wall and the muscles over the Transversus Abdominis muscle. The goal of the investigation was to determine the efficacy of 0.25 percent Levobupivacaine and 0.5 percent Ropivacaine as analgesics in the Transversus Abdominis Plane Block for Post-Surgical Analgesia after Lower Abdominal Surgery.
Material and Methods: 60 patients between the ages of 18 and 60 who underwent elective lower abdominal surgery and had an ASA grade I or II were included in the study. The TAP block was given using a double pop technique with an 18 gauge hypodermic needle. Rescue analgesia was provided postoperatively for a VAS of greater than 4. The drug of choice for treating pain was injection Tramadol. The criteria for rescue analgesia were also examined.
Results: Both categories were equal in the demographic information. The diagnosis and the procedures carried out were the same in both courses. The drop in VAS score was equivalent in both classes. (P> 0.05). In the postoperative stage, rescue analgesia was required in both classes.
Conclusion: Following lower abdominal surgery, Levobupivacaine and Ropivacaine produce comparable analgesia in the Transversus Abdominis Plane Block for Post-Surgical Analgesia.
Keywords:
  • PDF (238 K)
  • XML
(2022). Comparative Study of Efficacy of 0.5% Ropivacaine and 0.25% Levobupivacaine When Used in Transversus Abdominis Plane Block for Post-Operative Analgesia in Lower Abdominal Surgeries. European Journal of Molecular & Clinical Medicine, 9(6), 1313-1321.
Dr. Satyendra Kumar, Dr. Zubia Anjum, Dr. [Prof.] Ashok Kumar, Dr. Bijoy Kumar,. "Comparative Study of Efficacy of 0.5% Ropivacaine and 0.25% Levobupivacaine When Used in Transversus Abdominis Plane Block for Post-Operative Analgesia in Lower Abdominal Surgeries". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 1313-1321.
(2022). 'Comparative Study of Efficacy of 0.5% Ropivacaine and 0.25% Levobupivacaine When Used in Transversus Abdominis Plane Block for Post-Operative Analgesia in Lower Abdominal Surgeries', European Journal of Molecular & Clinical Medicine, 9(6), pp. 1313-1321.
Comparative Study of Efficacy of 0.5% Ropivacaine and 0.25% Levobupivacaine When Used in Transversus Abdominis Plane Block for Post-Operative Analgesia in Lower Abdominal Surgeries. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 1313-1321.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 35
  • PDF Download: 36
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus